Your browser doesn't support javascript.
loading
Synthesis and structure-activity relationships of teixobactin.
Karas, John A; Chen, Fan; Schneider-Futschik, Elena K; Kang, Zhisen; Hussein, Maytham; Swarbrick, James; Hoyer, Daniel; Giltrap, Andrew M; Payne, Richard J; Li, Jian; Velkov, Tony.
Afiliação
  • Karas JA; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Chen F; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Schneider-Futschik EK; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Kang Z; Lung Health Research Centre, Department of Pharmacology & Therapeutics, the University of Melbourne, Parkville, Victoria, Australia.
  • Hussein M; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Swarbrick J; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Hoyer D; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Giltrap AM; Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Parkville, Victoria, Australia.
  • Payne RJ; The Florey Institute of Neuroscience and Mental Health, the University of Melbourne, Parkville, Victoria, Australia.
  • Li J; Department of Molecular Medicine, the Scripps Research Institute, La Jolla, California.
  • Velkov T; School of Chemistry, the University of Sydney, Sydney, New South Wales, Australia.
Ann N Y Acad Sci ; 1459(1): 86-105, 2020 01.
Article em En | MEDLINE | ID: mdl-31792983
The discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial activity against several Gram positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. One of the key features of teixobactin as an antibiotic lead is that resistance could not be generated in a laboratory setting. This is proposed to be a result of a mechanism of action that involves binding to essential cell wall synthesis building blocks, lipid II and lipid III. Since the initial isolation report in 2015, significant efforts have been made to understand its unique mechanism of action, develop efficient synthetic routes for its production, and thus enable the generation of analogues for structure-activity relationship studies and optimization of its pharmacological properties. Our review provides a comprehensive treatise on the progress in understanding teixobactin chemistry, structure-activity relationships, and mechanisms of antibacterial activity. Teixobactin represents an exciting starting point for the development of new antibiotics that can be used to combat multidrug-resistant bacterial ("superbug") infections.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Depsipeptídeos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Depsipeptídeos Idioma: En Ano de publicação: 2020 Tipo de documento: Article